Chargement en cours...
Combating acquired resistance to tyrosine kinase inhibitors in lung cancer
The prospective identification and therapeutic targeting of oncogenic tyrosine kinases with tyrosine kinase inhibitors (TKIs) has revolutionized the treatment of patients with non-small cell lung cancer (NSCLC). TKI therapy frequently induces dramatic clinical responses in molecularly defined cohort...
Enregistré dans:
| Publié dans: | Am Soc Clin Oncol Educ Book |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734636/ https://ncbi.nlm.nih.gov/pubmed/25993168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14694/EdBook_AM.2015.35.e165 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|